4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-006211
SVP & Chief Accounting Officer sold 75,000 shares at $18.62 ($1,396,500)
- SVP & Chief Accounting Officer acquired 75,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Thomsen Jillian B. · SVP & Chief Accounting Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-28 | Exercise or conversion : show line 1 in the form | +37,500 | $8.80 | $330,000 | 213,757 | D |
| 2021-01-28 | Exercise or conversion : show line 2 in the form | +37,500 | $8.80 | $330,000 | 251,257 | D |
| 2021-01-28 | Sale : show line 3 in the form | −75,000 | $18.62 | $1,396,500 | 176,257 | D |
| Open-market sales · 75,000 sh · avg $18.62 · $1,396,500 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-28 | Exercise or conversion : show line 4 in the form Stock Option | −37,500 | 0 | D |
| 2021-01-28 | Exercise or conversion : show line 5 in the form Stock Option | −37,500 | 0 | D |
Loading xslF345X03/doc4.xml…